We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Medica Corporation

Medica markets and sells in vitro diagnostic analyzers, such as clinical chemistry analyzers, electrolyte analyzers, ... read more Featured Products: More products

Download Mobile App




Distribution Agreement Signed for Assistant Digital Cell Imaging System

By LabMedica International staff writers
Posted on 19 May 2014
Print article
Image: Medica EasyCell assistant (Photo courtesy of Medica Corporation).
Image: Medica EasyCell assistant (Photo courtesy of Medica Corporation).
HORIBA Medical (Montpellier, France) and Medica Corporation (Bedford, MA, USA) have entered into a nonexclusive agreement for the worldwide distribution of the EasyCell assistant digital hematology cell imaging system for use in hospitals and clinical laboratories worldwide.

The EasyCell assistant automatically locates white cells on a blood smear and preclassifies them on a display, grouped by cell type. The system displays images of red cells and platelets for performance of red cell morphology and platelet estimates. The EasyCell also features Remote Viewing Software for sharing of cell images throughout the hospital and Competency Review Software for training of medical technologists in the hematology laboratory.

Olivier Pou, corporate marketing director, HORIBA Medical commented on the agreement with the Medica Corp., "The EasyCell assistant is an important addition to our hematology product range and is a good match with our five-part differential hematology instrument portfolio. The addition of the Medica EasyCell assistant to our product offering makes it possible for HORIBA Medical to provide a complete range of advanced technology to our hematology customers, worldwide."

Medica Corp. uses its proprietary technology to manufacture easy-to-use, low-cost, blood testing analyzers. The analyzers are easy to operate and service and can be used routinely by personnel with a wide range of skill levels in hospital laboratories.

HORIBA Medical provides an extensive and complete line of hematology and clinical chemistry analyzers (including reagents) for in vitro medical diagnostics.

Related Links:

HORIBA Medical
Medica Corporation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.